Page 1 of Clinical Trials for PKC Inhibitor, 40 Total Matches
- 1CompletedLast Updated: October 31, 2009Condition(s): Bipolar Disorder
- 2RecruitingLast Updated: November 13, 2009Condition(s): Lung Cancer
- 3CompletedLast Updated: December 12, 2006Condition(s): Bipolar Disorder
- 4CompletedLast Updated: October 30, 2007Condition(s): Diabetes Mellitus
- 5CompletedLast Updated: November 18, 2009Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndromes
- 6RecruitingLast Updated: April 27, 2012Condition(s): Diffuse Large B-Cell Lymphoma
- 7CompletedOpen-label Multicenter Study of PKC412 in Pts With AML and MDS With Either Wild-type or Mutated FLT3Last Updated: May 1, 2012Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome
- 8CompletedLast Updated: January 17, 2008Condition(s): Diabetic Retinopathy
- 9CompletedLast Updated: June 4, 2007Condition(s): Diabetes Mellitus
- 10Active, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSLast Updated: May 10, 2012Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome
- 11CompletedLast Updated: July 23, 2008Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 12RecruitingLast Updated: December 15, 2011Condition(s): Adenocarcinoma of the Rectum
- 13CompletedLast Updated: October 5, 2009Condition(s): Diabetes Mellitus, Type 1
- 14RecruitingLast Updated: September 19, 2011Condition(s): Leukemia, Myeloid, Acute
- 15Active, not recruitingLast Updated: July 23, 2008Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 16RecruitingLast Updated: June 22, 2011Condition(s): Uveal Melanoma
- 17RecruitingLast Updated: March 30, 2012Condition(s): Uveal Melanoma
- 18CompletedLast Updated: July 23, 2008Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 19CompletedLast Updated: February 6, 2009Condition(s): Lung Cancer
- 20CompletedLast Updated: August 31, 2011Condition(s): Myocardial Infarction
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=PKC+Inhibitor
